1021

GDT Ontario Health Testing Eligibility HCT v3 GTD Indications Diagnosis Carrier / Cascade Testing GTD Samples Accepted Blood DNA GTD Test Methodology Sequencing GTD Methodology Notes Targeted Sanger sequencing for 3 BRCA1/BRCA2 pathogenic founder variants Generic Test name (cms title) Ashkenazi Jewish Panel GTD Test type Targeted Variant GTD Location Children's Hospital of Eastern Ontario GTD Gene/Platform/Region List BRCA1 (c.5266dupC), BRCA1 (c.68_69delAG), BRCA2 (c.5946delT)
GTD Category Cancer GTD Disease/Condition Hereditary Breast Cancer (Ashkenazi Jewish mutations)